News Focus
News Focus
Post# of 257432
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 202433

Tuesday, 07/12/2016 9:08:36 PM

Tuesday, July 12, 2016 9:08:36 PM

Post# of 257432
JUNO +24%/PM on resumption of interrupted phase-2 trial—without fludarabine:

http://finance.yahoo.com/news/juno-therapeutics-resume-jcar015-phase-205000686.html

Under the revised protocol, the ROCKET trial will continue enrollment using JCAR015 with cyclophosphamide pre-conditioning only.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today